Although the mechanism involving CypA blood level in AD pathophysiology still needs to be elucidated, the results of serum CypA correlation with global/regional GMV supports the usefulness of blood CypA level for identifying AD or aMCI among the elderly. The gene discussed is PPIA; the disease is Alzheimer disease.